Publication
Phosphite-derivatized ruthenium-carbohydrate complexes in the catalytic hydration of nitriles
Related publications (36)
Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand
Paul Joseph Dyson, Angela Casini, Fabio Edafe
The dinuclear dichloro complexes [(η6-arene)2Ru2(μ-Cl)2Cl2] and [(η5-C5Me5)2M2(μ-Cl)2Cl2] react with 2-(pyridine-2-yl)thiazole (pyTz) to afford the cationic complexes [(η6-arene)Ru(pyTz)Cl]+ (arene = C6H6 (1), p-iPrC6H4Me (2) or C6Me6 (3)) and [(η5-C5Me5)M ...
Elsevier2010Femtosecond XANES Study of the Light-Induced Spin Crossover Dynamics in an Iron(II) Complex
Majed Chergui, Paul Beaud, Wojciech Gawelda, Camelia Borca, Van Thai Pham, Renske Marjan van der Veen
X-ray absorption spectroscopy is a powerful probe of mol. structure, but it has previously been too slow to track the earliest dynamics after photoexcitation. We investigated the ultrafast formation of the lowest quintet state of aq. iron(II) tris(bipyridi ...
2009Catalytic Asymmetric Passerini-Type Reaction: Chiral Aluminum-Organophosphate-Catalyzed Enantioselective alpha -Addition of Isocyanides to Aldehydes
A chiral Lewis acid catalyst was prepd. by mixing 2 equiv of chiral binol-derived organophosphoric acid and 1 equiv of Et2AlCl. In the presence of a catalytic amt. of [I]2Al(III)Cl complex (0.05 equiv), reaction between alpha -isocyanoacetamides and aldehy ...
2009Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds
Paul Joseph Dyson, Rosario Scopelliti, Christian Hartinger, Antoine Dorcier
The reactions of arene-metal complexes (arene = p-cymene, benzene or pentamethylcyclopentadienyl, metal = Ru, Rh or Os), including 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decanephosphine (pta) and chloro co-ligands, with 9-methylguanine, adenine, and a ser ...
2008Novel strategies for overcoming drug resistance in transition metal-based anticancer compounds
Cisplatin is one of the most important and widely used anticancer drug in clinical use. However, its effectiveness is limited by its high toxicity and incidence of drug resistance. This has provided motivation for the search for transition metal-based drug ...
EPFL2007Structure, dynamics and catalytic activity of ruthenium(II)-arene phosphine complexes
This thesis encompasses work on the coordination chemistry and catalytic activity of half sandwich ruthenium(II)-arene phosphine complexes. The investigation of phosphine dissociation and association reactions of these complexes represents the unifying the ...
EPFL2007Chiral Salen-Aluminum Complex as a Catalyst for Enantioselective alpha -Addition of Isocyanides to Aldehydes: Asymmetric Synthesis of 2-(1-Hydroxyalkyl)-5-aminooxazoles
In the presence of a catalytic amt. of (Schiff base)Al(III)Cl complex (Schiff base of (R,R)-1,2-cyclohexanediamine with 3,5-di-tert-butyl-2-hydroxybenzaldehyde), reaction between alpha -isocyanoacetamides and aldehydes afforded the corresponding 5-aminooxa ...
2007Syntheses and Structures of the Trinuclear Ruthenium Complexes [RuCl2(PAd2Bu)]3 and [RuCl2(PtBu2Cy)]3
Rosario Scopelliti, Kay Severin, Sébastien Gauthier
The trinuclear Ru complexes [RuCl2(PAd2Bu)]3 (1) and [RuCl2(PtBu2Cy)]3 (2) were obtained by reaction of [(p-cymene)RuCl2]2 with 2 equiv of the resp. sterically demanding phosphine. Crystallog. analyses of 1 and 2 show that the three metal fragments are con ...
2005Electrocatalytic hydrogen evolution by cobalt difluoroboryl-diglyoximate complexes
In the presence of moderately strong acids in MeCN, Co complexes with BF2-bridged diglyoxime ligands are active catalysts for the redn. of protons to H2 at potentials as pos. as -0.28 V vs. SCE. [on SciFinder (R)] ...
2005Preparation of (ethylene)-(propylene)-triaminepentaacetic acid derivatives for use in the production of pharmaceutical agents
André Merbach, Eva Jakab Toth, Sabrina Laus
The invention relates to a novel class of ligands, complexes comprising such ligands and a metal ion, and adducts of these metal complexes and a macromolecule. Pharmaceutical compositions and methods of making and using the ligand-metal complexes are also ...
2003